Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10861370 | PMC |
| http://dx.doi.org/10.3960/jslrt.23043 | DOI Listing |
Publication Analysis
Top Keywords
r-mini-chp combination
4
combination polatuzumab
4
polatuzumab vedotin
4
vedotin pola-r-mini-chp
4
pola-r-mini-chp primary
4
primary treatment
4
treatment ≥80-year-old
4
≥80-year-old cases
4
cases diffuse
4
diffuse large
4
Similar Publications
Use of R-mini-CHP in combination with polatuzumab vedotin (pola-R-mini-CHP) as the primary treatment in ≥80-year-old cases with diffuse large B-cell lymphoma.
J Clin Exp Hematop
December 2023
Department of Hematology, Saitama Cancer Center, Saitama, Japan.
Successful Use of a Multidisciplinary Approach to Treat a Perforated Duodenal Malignant Lymphoma in an Elderly Patient.
Case Rep Oncol Med
April 2018
Department of Surgery, Uji Tokushukai Medical Center, Uji, Kyoto 611-0041, Japan.
Treatment of duodenal malignant lymphoma is difficult due to life-threatening complications such as intestinal obstruction, perforation, and pancreatitis. Thus, multidisciplinary procedures are required alongside surgical intervention. Contrast abdominal CT images of a 75-year-old female suffering from vomiting revealed thickening of the duodenal wall (from the second to third segment).
View Article and Find Full Text PDF